Rabevib L Capsule SR
Manufacturer
Vibcare Pharma Pvt Ltd
Salt Composition
Levosulpiride (75mg) + Rabeprazole (20mg)
Key Information
Short Description
Rabevib L Capsule SR is a prescription medicine used to treat gastroesophageal reflux disease (acid reflux), intestinal ulcers, and irritable bowel syndrome.
Dosage Form
Capsule SR
Introduction
Rabevib L Capsule SR is taken with or without food in a dose and duration as advised by the doctor. The dose you are given will depend on your condition and how you respond to the medicine. You should keep taking this medicine for as long as your doctor recommends. If you stop treatment too early your symptoms may come back and your condition may worsen. Let your healthcare team know about all other medications you are taking as some may affect or be affected by this medicine.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Rabevib L Capsule SR is to be taken empty stomach.
Safety Information
Side Effects
Nausea Stomach pain Diarrhea Flatulence Constipation Headache Weakness Flu-like symptoms
Alcohol Warning
It is unsafe to consume alcohol with Rabevib L Capsule SR.
Breastfeeding Warning
Information regarding the use of Rabevib L Capsule SR during breastfeeding is not available. Please consult your doctor.
Pregnancy Warning
Rabevib L Capsule SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Rabevib L Capsule SR is a combination of two medicines: Levosulpiride and Rabeprazole.
Quick Tips
It is a well-tolerated medicine and provides relief for a long time. Take it one hour before the meal preferably in the morning. Inform your doctor if you get watery diarrhea, fever, or stomach pain that does not go away. Do not consume alcohol while taking Rabevib L Capsule SR as it can increase the risk of stomach damage. Long-term use may cause weak or broken bones. Take adequate intake of dietary calcium and vitamin D or their supplements. Do not take Rabevib L Capsule SR for longer than prescribed.
Related Medicines
Rablet L Capsules
Colosafe-L Capsule SR
Ansuper-Plus Capsule SR
Rabemac LS Capsule
Razo-L Capsule
Veloz L Capsule
Acera-L Capsule SR
Rabonik Plus Capsule SR
Rabzoc LS 75mg/20mg Capsule SR
Rabeflow LS 75mg/20mg Capsule SR
Frequently asked questions
What is the optimal time to take Rabevib L Capsule SR?
Take Rabevib L Capsule SR exactly as directed by your doctor. It is best taken once daily on an empty stomach.
Are there any contraindications associated with the use of Rabevib L Capsule SR?
Use of Rabevib L Capsule SR should be avoided in patients with known allergies to any of the components or excipients of this medicine.
Can the use of Rabevib L Capsule SR lead to dizziness?
Yes, some individuals may experience dizziness (feeling faint, weak, unsteady, or lightheaded) while taking Rabevib L Capsule SR. If you feel dizzy or lightheaded, it is advisable to rest and resume once you feel better.
Does the use of Rabevib L Capsule SR raise the risk of fractures?
Several studies in adults suggest that treatment with Rabevib L Capsule SR may be associated with an increased risk of osteoporosis-related fractures of the hip, wrist, or spine. The risk of fracture was higher in patients receiving high doses. High dose can mean multiple daily doses and long-term therapy (a year or longer).
Can I drive while taking Rabevib L Capsule SR?
Rabevib L Capsule SR may cause drowsiness, dizziness, or impaired vision. It is not advisable to operate machinery or drive until you understand how this medicine affects you.
What are the storage and disposal instructions for Rabevib L Capsule SR?
Store Rabevib L Capsule SR in its original packaging, tightly sealed. Follow the storage instructions on the label or packaging. Dispose of unused medication properly. Keep it out of reach of pets, children, and other individuals.
